Search

everythinglearnresearchcommunity

for

Search:↓

Generative AI tools can accurately score alopecia areata, reducing subjectivity in evaluations.

Anagen effluvium is a reversible condition causing sudden hair loss, often due to chemotherapy or head radiation.

CD73 may regulate hair growth and could be targeted for hair growth treatments.

A liver transplant patient with APECED had a rare VZV recurrence and pneumonia, treated successfully, but later died from other infections.

Taurine and apocynin together improve burn healing, especially later in recovery.

EDA2R gene linked to hair loss.

Ascorbic acid derivatives improve drug delivery systems.

Personalized treatment plans are important for people with alopecia areata.

ELIP-based CRISPR delivery improves heart disease gene editing but needs more testing.

Researchers created a system that accurately aligns laser beams automatically.

IVIG therapy significantly improved symptoms in a patient with APS-2 and SPS.

The study identified key immune cell differences between mild and severe alopecia areata.

A new tool simplifies alopecia areata severity scoring but needs validation.

EPDS and MS might share an immune-related cause.

Good communication helps predict successful aging in older Indonesians.

Medicare Part D causes significant coverage and cost issues for end-stage renal disease patients.

Both azathioprine and betamethasone treatments help with hair regrowth in alopecia areata, but azathioprine may have fewer side effects.

New genetic mutations causing hair loss were found in a Chinese family.

Congenital alopecia areata may have genetic links and topical corticosteroids are an effective treatment.

PRP treatments for hair loss need standard protocols to be reliable.

The document's conclusion cannot be provided because the document is not available to parse.

Pmg-1 and Pmg-2 are new genes important for skin and mammary gland development.

CE-PTG detects early hair follicle issues in balding areas, helping measure male hair loss.

Cathepsin E is crucial for normal skin cell differentiation and development.

Alopecia areata was successfully treated with contact immunotherapy, oral antihistamines, and topical corticosteroids.

The combined therapy was effective and safe for children with severe alopecia areata.

Diphencyprone treatment increases CD8 lymphocytes in the scalp, which is associated with hair regrowth in alopecia areata patients.

New ABCA12 gene mutations were linked to a skin condition with scaling and hair loss, and a treatment helped with hair loss in a related case.